Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. (original) (raw)

Research Article Free access | 10.1172/JCI119798

J Gosling, S W Chensue, S L Kunkel, R V Farese Jr, H E Broxmeyer, and I F Charo

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Boring, L. in:JCI |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Gosling, J. in:JCI |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Chensue, S. in:[JCI](/search/results?q=author.first%5Fname%3A%22S W%22+author.last%5Fname%3A%22Chensue%22&search%5Ftype=advanced) |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Kunkel, S. in:[JCI](/search/results?q=author.first%5Fname%3A%22S L%22+author.last%5Fname%3A%22Kunkel%22&search%5Ftype=advanced) |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Farese, R. in:[JCI](/search/results?q=author.first%5Fname%3A%22R V%22+author.last%5Fname%3A%22Farese%22&search%5Ftype=advanced) |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Broxmeyer, H. in:[JCI](/search/results?q=author.first%5Fname%3A%22H E%22+author.last%5Fname%3A%22Broxmeyer%22&search%5Ftype=advanced) |PubMed |Google Scholar

Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100, USA.

Find articles by Charo, I. in:[JCI](/search/results?q=author.first%5Fname%3A%22I F%22+author.last%5Fname%3A%22Charo%22&search%5Ftype=advanced) |PubMed |Google Scholar

Published November 15, 1997 -More info

Published November 15, 1997 -Version history

View PDF

Abstract

Monocyte chemoattractant protein-1 (MCP-1) is a potent agonist for mononuclear leukocytes and has been implicated in the pathogenesis of atherosclerosis and granulomatous lung disease. To determine the role of MCP-1 and related family members in vivo, we used homologous recombination in embryonic stem cells to generate mice with a targeted disruption of C-C chemokine receptor 2 (CCR2), the receptor for MCP-1. CCR2-/- mice were born at the expected Mendelian ratios and developed normally. In response to thioglycollate, the recruitment of peritoneal macrophages decreased selectively. In in vitro chemotaxis assays, CCR2-/- leukocytes failed to migrate in response to MCP-1. Granulomatous lung disease was induced in presensitized mice by embolization with beads coupled to purified protein derivative (PPD) of Mycobacterium bovis. As compared with wild-type littermates, CCR2-/- mice had a decrease in granuloma size accompanied by a dramatic decrease in the level of interferon gamma in the draining lymph nodes. Production of interferon gamma was also decreased in PPD-sensitized splenocytes from CCR2-/- mice and in naive splenocytes activated by concanavalin A. We conclude that CCR2-/- mice have significant defects in both delayed-type hypersensitivity responses and production of Th1-type cytokines. These data suggest an important and unexpected role for CCR2 activation in modulating the immune response, as well as in recruiting monocytes/macrophages to sites of inflammation.

Version history